health
Vitruvias Therapeutics Thyroid Drug Recall Elevated to FDA’s Highest-Risk Class I Level -What It Means
Vitruvias Therapeutics, based in Auburn, Alabama, has issued a nationwide consumer-level recall of one lot of its Thyroid Tablets, USP 30 mg, following FDA confirmation that the medication could be superpotent. The post Vitruvias Therapeutics Thyroid Drug Recall Elevated to FDA’s Highest-Risk Class I Level -What It Means appeared first on The Sunday Guardian .
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
Drug Topics
Smartphone retinal imaging could expand global eye care screening
News-Medical
Why does endometriosis only cause major pain for some?
Futurity
Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18